Navigation Links
MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics
Date:4/7/2008

Clinical proof of concept achieved with proprietary drug combination

technology

MOUNTAIN VIEW, Calif., April 7, 2008 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP), today announced positive results from a Phase 2a clinical study evaluating MAP0005 for the potential treatment of asthma and chronic obstructive pulmonary disease (COPD). MAP0005 is a single-particle combination of budesonide, a corticosteroid, and formoterol, a long-acting beta2-agonist, delivered to the respiratory tract using the Company's proprietary Tempo(R) inhaler.

"The results of our Phase 2a trial with MAP0005 demonstrate our ability to apply our proprietary technologies to combine two drugs within a single particle in a pre-specified ratio and deliver them to the lung," said Timothy S. Nelson, President and Chief Executive Officer of MAP Pharmaceuticals. "We believe this approach has the potential to address formulation and stability constraints often seen in the development and production of inhaled combination products. Our goal is to improve safety and efficacy by targeting consistent dose ratios and reducing systemic exposure to the beta-agonist. This approach has potential broad applicability for additional combination product candidates in a variety of indications."

This randomized, open-label, active-controlled, crossover, safety and dose response study investigated the pharmacokinetics (PK) and pharmacodynamics of MAP0005 in 15 adult asthmatics. The trial assessed the ability of MAP0005 to deliver budesonide to the lungs, as measured by PK, and formoterol to conducting airways in amounts sufficient to provide bronchodilation, both compared to the leading currently approved budesonide/
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program
2. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
3. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
4. EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia
5. ISTA Pharmaceuticals Announces Results of Clinical Trial of Xibrom(TM) QD (Once-Daily) Formulation
6. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
7. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
8. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
9. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
10. Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients
11. NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 5, 2015 Oramed ... ), a clinical-stage pharmaceutical company focused on the ... that the company will present at the following ... Annual Israeli Conference , ,Date:       ... Kidron , Chief Executive Officer ,Time:     ...
(Date:5/5/2015)... Faced with fast economy and population growth, an aging population, ... medical device industry has been growing rapidly in recent ... Beijing , Shanghai , ... the entry of a large number of medical device companies ... cities increasingly saturated. How do medical device enterprises look for ...
(Date:5/5/2015)... 2015  The Association of periOperative Registered Nurses (AORN) ... The Preoperative Stop and Go Sign designed by ... Gonzalez , M.D., anesthesia providers with Anaesthesia Associates ... Sign product is distributed by the Plexus Management ... is in compliance with the AORN Safe Surgery Checklist. ...
Breaking Medicine Technology:Oramed to Present at Upcoming Conferences 2Oramed to Present at Upcoming Conferences 3MEDITEXPO JIANGSU 2015 is to Help Medical Device Companies Explore Business Opportunities in Wider Markets 2MEDITEXPO JIANGSU 2015 is to Help Medical Device Companies Explore Business Opportunities in Wider Markets 3MEDITEXPO JIANGSU 2015 is to Help Medical Device Companies Explore Business Opportunities in Wider Markets 4The Preoperative Stop and Go Sign Interactive Checklist Awarded AORN Seal of Recognition 2The Preoperative Stop and Go Sign Interactive Checklist Awarded AORN Seal of Recognition 3
... St. Jude Medical, Inc. (NYSE: STJ ... they have entered into partnership with a focus on iRhythm,s ... million private equity round of financing, which was led ... Ventures and Synergy Life Science Partners. Proceeds will be used ...
... HARBIN, China , May 13 ... or "the Company") (Nasdaq: CSKI ), a leading,fully integrated pharmaceutical ... ("PRC"), today announced that Mr. Stanley Hao ,the Company,s Chief ... 2010 . , , CCG China Rising Investment ...
Cached Medicine Technology:St. Jude Medical and iRhythm Technologies Enter into Partnership to Co-Market Novel Cardiac Rhythm Monitor 2St. Jude Medical and iRhythm Technologies Enter into Partnership to Co-Market Novel Cardiac Rhythm Monitor 3China Sky One Medical to Attend Investment Conferences in May 2
(Date:5/5/2015)... May 05, 2015 With Mother's ... Organics, one of the country's leading organic vegetable ... of moms across the country. What to eat? ... recipe box or spend hours browsing Pinterest – ... http://www.josiesorganics.com/recipes . , The new recipes ...
(Date:5/5/2015)... 2015 In the upbeat Moms Helping Moms ... moms to support each other. Parenting is a tough ... makes it so much easier. Mothers talk about how ... less alone and help them realize there’s no perfect parent; ... who are clearly dear friends share that it's just that, ...
(Date:5/5/2015)... May is National Osteoporosis Month, and also ... Better Bone Health . Founded by Charles T. Price, MD, ... consumers and physicians about the latest advances in bone care, ... According to a study recently published by the Journal of ... by osteoporosis and low bone mass. This breaks down to ...
(Date:5/5/2015)... After record-breaking sales of Extend ... introduces the Cookies & Cream flavor at stores nationwide ... has continually raised the bar for nutritional snacks. ... an unprecedented nutritional profile, backed by international patents and ... will launch additional new products and expand retail availability ...
(Date:5/5/2015)... Dealing with injuries and medical expenses following ... Personal injury lawyers are excellent resources for accident victims throughout ... their latest article , the Jones Firm gives the top ... a personal injury lawyer to handle their case. , Working ... waste of time if the lawyer does not have a ...
Breaking Medicine News(10 mins):Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 2Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 3Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 4Health News:Just In Time For Mother’s Day, Healthy Birth Day Releases Video Titled “Moms Helping Moms” Encouraging Mothers To Band Together 2Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 2Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4Health News:5 Top Qualifications for Personal Injury Lawyer Disclosed in Latest Article by The Jones Firm 2
... By Amanda Gardner HealthDay Reporter , ... simulation model, researchers say they,ve determined that relying on ... is a "reasonable approach" and alternative to immediate treatment, ... and impotence. If the tumor were to start ...
... or through an employed family member,s dependent coverage. Yet having ... new policy brief from the UCLA Center for Health Policy ... Interview Survey (CHIS), the brief,s authors found that one-fifth of ... least one employed family member or 5.7 million ...
... The American Society of Hematology (ASH) will host its ... Convention Center in Orlando, FL, December 4-7. More than ... highlight emerging research trends in the diagnosis, treatment, and ... pleasure to host the 2010 ASH annual meeting, which ...
... be one of the world,s first medicinal body piercings, UC ... implanted an experimental device in the throat of a man ... swallow. The device, which could offer an effective treatment option ... pulling on a tiny metal pin that extends through the ...
... to lower rates of child sex abuse? It could ... Diamond, from the University of Hawaii, and colleagues. , ... else studied (Canada, Croatia, Denmark, Germany, Finland, Hong Kong, ... have not increased following the legalization and wide availability ...
... This release is available in French . ... turn to alternative therapies to treat their children,s asthma, according ... findings, published recently in the Canadian Respiratory Journal , ... rate of poor asthma control in children. "Previous studies ...
Cached Medicine News:Health News:Study Backs 'Active Surveillance' for Low-Risk Prostate Cancer 2Health News:Study Backs 'Active Surveillance' for Low-Risk Prostate Cancer 3Health News:5.7 million Californians lack access to job-based coverage 2Health News:ASH's 52nd Annual Meeting and Exposition showcases the latest advances in the field 2Health News:ASH's 52nd Annual Meeting and Exposition showcases the latest advances in the field 3Health News:UC Davis surgeons test innovative device in patient with swallowing disorder 2Health News:UC Davis surgeons test innovative device in patient with swallowing disorder 3Health News:Legalizing child pornography is linked to lower rates of child sex abuse 2Health News:Alternative therapies may leave asthmatics gasping 2
Solid 14 mm blades. Dull finish....
Angled for temporal approach. Open 14 mm rounded blades for patient comfort. Dull finish....
Open 14 mm blades of heavy 1 mm wire. Dull finish. Most popular size or model....
Open wire style blades allow complete manipulation of the phaco tip inside the eye. Lid control is excellent, exposure is maximized, and the likelihood of positive pressure is reduced....
Medicine Products: